Top

Gepubliceerd in:

06-01-2022

Socio-behavioral factors related to PrEP non-adherence among gay male PrEP users living in California and New York: A behavioral theory informed approach

Auteurs: Minhao Dai, Christopher Calabrese

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 2/2022

Abstract

One effective preventative measure to reduce the number of new HIV infections is through the uptake of daily oral HIV pre-exposure prophylaxis (PrEP). Although previous clinical trials have proven the effectiveness of on-demand PrEP uptake, daily PrEP uptake is the most popular prevention method among PrEP users and is still recommended by most healthcare professionals and organizations. Informed by the integrative model of behavioral prediction, the current study examined the socio-behavioral factors associated with PrEP non-adherence. The present study conducted a cross-sectional survey of 210 gay male daily PrEP users living in California and New York. The results showed more than two-thirds of the sample indicated that they had skipped taking PrEP within the last 30 days, averaging around four to five missed doses. General attitudes toward desirable and undesirable outcomes, perceived behavioral control, and social-level barriers were associated with daily PrEP uptake non-adherence. The findings highlight providers’ role in PrEP adherence and the importance of habit-forming, which can be enhanced by cost-effective strategies and technological innovations.

vorige artikel Effects of 6-month episodic future thinking training on delay discounting, weight loss and HbA1c changes in individuals with prediabetes

volgende artikel Psychosocial and behavioral correlates of weight loss 12 to 15 years after bariatric surgery

Abaasa, A., Hendrix, C., Gandhi, M., Anderson, P., Kamali, A., Kibengo, F., Sanders, E. J., Mutua, G., Bumpus, N. N., Priddy, F., & Haberer, J. E. (2018). Utility of different adherence measures for PrEP: Patterns and incremental value. AIDS and Behavior, 22(4), 1165–1173. https://doi.org/10.1007/s10461-017-1951-yCrossRefPubMed

AIDSVu. (2019). Mapping PrEP: First-ever data on PrEP users across the U.S. https://aidsvu.org/prep/.

Baker, Z., Javanbakht, M., Mierzwa, S., Pavel, C., Lally, M., Zimet, G., & Gorbach, P. (2018). Predictors of over-reporting HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) in self-reported versus biomarker data. AIDS and Behavior, 22(4), 1174–1183. https://doi.org/10.1007/s10461-017-1958-4CrossRefPubMedPubMedCentral

Baxi, S. M., Liu, A., Bacchetti, P., Mutua, G., Sanders, E. J., Kibengo, F. M., Haberer, J. E., Rooney, J., Hendrix, C. W., Anderson, P. L., Huang, Y., Priddy, F., & Gandhi, M. (2015). Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(1), 13–20. https://doi.org/10.1097/QAI.0000000000000386CrossRefPubMed

Blumenthal, J., Pasipanodya, E. C., Jain, S., Sun, S., Ellorin, E., Morris, S., & Moore, D. J. (2019). Comparing self-report pre-exposure prophylaxis adherence questions to pharmacologic measures of recent and cumulative pre-exposure prophylaxis exposure. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.00721CrossRefPubMedPubMedCentral

Boas, T. C., Christenson, D. P., & Glick, D. M. (2020). Recruiting large online samples in the United States and India: Facebook, Mechanical Turk, and Qualtrics. Political Science Research and Methods, 8(2), 232–250. https://doi.org/10.1017/psrm.2018.28CrossRef

Carey, M. P., & Schroder, K. E. E. (2002). Development and psychometric evaluation of the brief HIV knowledge questionnaire. AIDS Education and Prevention, 14(2), 172–182. https://doi.org/10.1521/aeap.14.2.172.23902CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention. (2018). US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: A clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf.

Centers for Disease Control and Prevention. (2019, October 21). Talking to your patients | Treatment, care, and prevention for people with HIV | Clinicians | HIV | CDC. https://www.cdc.gov/hiv/clinicians/treatment/patient-provider.html

Centers for Disease Control and Prevention. (2020). Estimated HIV incidence and prevalence in the United States 2014–2018. 23. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html

Chou, W. Y. S., Oh, A., & Klein, W. M. P. (2018). Addressing health-related misinformation on social media. JAMA, 320(23), 2417. https://doi.org/10.1001/jama.2018.16865CrossRefPubMed

Dai, M., & Harrington, N. (2021a). Understanding beliefs, intention, and behavior on daily PrEP uptake among MSM in California and New York. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education, 33(2), 129–142. https://doi.org/10.1521/aeap.2021.33.2.129CrossRef

Dai, M., & Harrington, N. G. (2021b). Intention to behavior: Using the integrative model of behavioral prediction to understand actual control of PrEP uptake among gay men. Archives of Sexual Behavior, 50(4), 1817–1828. https://doi.org/10.1007/s10508-020-01802-yCrossRefPubMed

Dai, M., Wombacher, K., Matig, J. J., & Harrington, N. G. (2018). Using the integrative model of behavioral prediction to understand college students’ hookup sex beliefs, intentions, and behaviors. Health Communication, 33(9), 1078–1087. https://doi.org/10.1080/10410236.2017.1331306CrossRefPubMed

Dreisbach, E. N. (2020, September 30). Truvada patent expires, potentially opening ‘new doors’ for PrEP access. Healio. https://www.healio.com/news/infectious-disease/20200930/truvada-patent-expires-potentially-opening-new-doors-for-prep-access

Fishbein, M., & Ajzen, I. (2011). Predicting and changing behavior: The reasoned action approach. Psychology Press. https://doi.org/10.4324/9780203838020CrossRef

Grov, C., D’Angelo, A. B., Flynn, A. W. P., Lopez-Rios, J., Pantalone, D. W., Holloway, I. W., Whitfield, T. H. F., & Parsons, J. T. (2018). How do gay and bisexual men make up for missed PrEP doses, and what impact does missing a dose have on their subsequent sexual behavior? AIDS Education and Prevention, 30(4), 275–286. https://doi.org/10.1521/aeap.2018.30.4.275CrossRefPubMedPubMedCentral

Grov, C., Flynn, A. W. P., D’Angelo, A. B., Lopez-Rios, J., Pantalone, D. W., Holloway, I. W., & Parsons, J. T. (2019). Gay and bisexual men’s strategies to maintain daily adherence to their HIV pre-exposure prophylaxis (PrEP) medication: Results from a qualitative study. Prevention Science, 20(1), 168–177. https://doi.org/10.1007/s11121-019-0985-yCrossRefPubMedPubMedCentral

Harkness, A., Bainter, S. A., Mendez, N. A., Hernandez Altamirano, D., O’Cleirigh, C., Mimiaga, M. J., Mayer, K. H., & Safren, S. A. (2021). Factors associated with barriers to engagement in HIV-prevention care among sexual minority men. Journal of Behavioral Medicine. https://doi.org/10.1007/s10865-021-00230-0CrossRefPubMed

Harris, N. S. (2019). Vital signs: Status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis—United States, 2013–2018. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6848e1CrossRefPubMedPubMedCentral

Holloway, I., Dougherty, R., Gildner, J., Beougher, S. C., Pulsipher, C., Montoya, J. A., Plant, A., & Leibowitz, A. (2017). PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. Journal of Acquired Immune Deficiency Syndromes (1999), 74(1), 15–20. https://doi.org/10.1097/QAI.0000000000001164CrossRef

Holloway, I. W., Krueger, E. A., Meyer, I. H., Lightfoot, M., Frost, D. M., & Hammack, P. L. (2020). Longitudinal trends in PrEP familiarity, attitudes, use and discontinuation among a national probability sample of gay and bisexual men, 2016–2018. PLoS ONE, 15(12), e0244448. https://doi.org/10.1371/journal.pone.0244448CrossRefPubMedPubMedCentral

Joint United Nations Programme on HIV/AIDS. (2019). UNAIDS data 2019. https://www.unaids.org/en/resources/documents/2019/2019-UNAIDS-data.

Liu, A. Y., Hessol, N. A., Vittinghoff, E., Amico, K. R., Kroboth, E., Fuchs, J., Irvin, R., Sineath, R. C., Sanchez, T., Sullivan, P. S., & Buchbinder, S. P. (2014). Medication adherence among men who have sex with men at risk for HIV infection in the United States: Implications for pre-exposure prophylaxis implementation. AIDS Patient Care and STDs, 28(12), 622–627. https://doi.org/10.1089/apc.2014.0195CrossRefPubMedPubMedCentral

Macapagal, K., Kraus, A., Korpak, A. K., Jozsa, K., & Moskowitz, D. A. (2020). PrEP awareness, uptake, barriers, and correlates among adolescents assigned male at birth who have sex with males in the U.S. Archives of Sexual Behavior, 49(1), 113–124. https://doi.org/10.1007/s10508-019-1429-2CrossRefPubMed

Mauro, J., Mathews, K. B., & Sredzinski, E. S. (2019). Effect of a smart pill bottle and pharmacist intervention on medication adherence in patients with multiple myeloma new to lenalidomide therapy. Journal of Managed Care & Specialty Pharmacy, 25(11), 1244–1254. https://doi.org/10.18553/jmcp.2019.25.11.1244CrossRef

Molina, J. M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., Raffi, F., Pintado, C., Chidiac, C., Chas, J., Charbonneau, P., Delaugerre, C., Suzan-Monti, M., Loze, B., Fonsart, J., … Delfraissy, J. F. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373(23), 2237–2246. https://doi.org/10.1056/NEJMoa1506273CrossRef

Molina, J.-M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., Tremblay, C., Rojas-Castro, D., Cua, E., Pasquet, A., Bernaud, C., Pintado, C., Delaugerre, C., Sagaon-Teyssier, L., Mestre, S. L., Chidiac, C., Pialoux, G., Ponscarme, D., Fonsart, J., … ANRS IPERGAY Study Group. (2017). Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: An observational cohort study. The Lancet. HIV, 4(9), e402–e410. https://doi.org/10.1016/S2352-3018(17)30089-9

Náfrádi, L., Nakamoto, K., & Schulz, P. J. (2017). Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS ONE, 12(10), e0186458. https://doi.org/10.1371/journal.pone.0186458CrossRefPubMedPubMedCentral

Owens, C., Hubach, R. D., Lester, J. N., Williams, D., Voorheis, E., Reece, M., & Dodge, B. (2020). Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM). AIDS Care. https://doi.org/10.1080/09540121.2020.1757021CrossRefPubMed

Patel, S., Jacobus-Kantor, L., Marshall, L., Ritchie, C., Kaplinski, M., Khurana, P. S., & Katz, R. J. (2013). Mobilizing Your medications: An automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. Journal of Diabetes Science and Technology, 7(3), 630–639. https://doi.org/10.1177/193229681300700307CrossRefPubMedPubMedCentral

Phillips, L. A., Cohen, J., Burns, E., Abrams, J., & Renninger, S. (2016). Self-management of chronic illness: The role of ‘habit’ versus reflective factors in exercise and medication adherence. Journal of Behavioral Medicine, 39(6), 1076–1091. https://doi.org/10.1007/s10865-016-9732-zCrossRefPubMed

Qu, D., Zhong, X., Xiao, G., Dai, J., Liang, H., & Huang, A. (2018). Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study. International Journal of Infectious Diseases, 75, 52–59. https://doi.org/10.1016/j.ijid.2018.08.006CrossRefPubMed

Robbins, R., & Niederdeppe, J. (2015). Using the integrative model of behavioral prediction to identify promising message strategies to promote healthy sleep behavior among college students. Health Communication, 30(1), 26–38. https://doi.org/10.1080/10410236.2013.835215CrossRefPubMed

Sidebottom, D., Ekström, A. M., & Strömdahl, S. (2018). A systematic review of adherence to oral pre-exposure prophylaxis for HIV – how can we improve uptake and adherence? BMC Infectious Diseases, 18(1), 581. https://doi.org/10.1186/s12879-018-3463-4CrossRefPubMedPubMedCentral

Smith, D. K., Van Handel, M., & Grey, J. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology, 28(12), 850-857.e9. https://doi.org/10.1016/j.annepidem.2018.05.003CrossRefPubMed

U.S. Food and Drug Administration (2019). FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. https://www.fda.gov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic

Wilson, K., Bleasdale, J., & Przybyla, S. M. (2020). Provider-patient communication on pre-exposure prophylaxis (PrEP) for HIV prevention: An exploration of healthcare provider challenges. Health Communication. https://doi.org/10.1080/10410236.2020.1787927CrossRefPubMed

Wood, S. M., Lee, S., Barg, F. K., Castillo, M., & Dowshen, N. (2017). Young transgender women’s attitudes toward HIV pre-exposure prophylaxis. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 60(5), 549–555. https://doi.org/10.1016/j.jadohealth.2016.12.004CrossRef

Wood, S., Gross, R., Shea, J. A., Bauermeister, J. A., Franklin, J., Petsis, D., Swyryn, M., Lalley-Chareczko, L., Koenig, H. C., & Dowshen, N. (2019). Barriers and facilitators of PrEP adherence for young men and transgender women of color. AIDS and Behavior, 23(10), 2719–2729. https://doi.org/10.1007/s10461-019-02502-yCrossRefPubMedPubMedCentral

World Health Organization. (2019). Ten threats to global health in 2019. https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019.

Titel: Socio-behavioral factors related to PrEP non-adherence among gay male PrEP users living in California and New York: A behavioral theory informed approach
Auteurs: Minhao Dai
Christopher Calabrese
Publicatiedatum: 06-01-2022
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 2/2022
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-021-00275-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2022

Psychosocial profiles and longitudinal achievement of optimal cardiovascular risk factor levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study

Psychosocial and behavioral correlates of weight loss 12 to 15 years after bariatric surgery

Psychological Impact of Ambiguous Health Messages about COVID-19

Changes in physical activity associated with the COVID-19 pandemic in individuals with overweight and obesity: an interrupted time series analysis with historical controls

Healthy or not? The impact of conflicting health-related information on attentional resources

Perceived discrimination, adherence to antiretroviral therapy, and HIV care engagement among HIV-positive black adults: the mediating role of medical mistrust